Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de LaBarre Michael J.. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que LaBarre Michael J. reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:HALO / Halozyme Therapeutics, Inc. SVP, CHIEF TECHNICAL OFFICER 173,756
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por LaBarre Michael J.. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas HALO / Halozyme Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em HALO / Halozyme Therapeutics, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Vendas Internas HALO / Halozyme Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em HALO / Halozyme Therapeutics, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2023-02-16 HALO LaBarre Michael J. 2,878 49.2600 2,878 49.2600 141,770 81 30.2800 -54,624 -38.53

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por LaBarre Michael J. conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 173,756 -0.06 58.74 -5,874 10,206,427
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,597 173,856 -0.91 58.25 -93,028 10,127,460
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 175,453 -0.34 58.65 -35,189 10,289,968
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,400 176,053 -5.07 58.09 -546,055 10,227,095
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 185,453 -0.38 58.67 -41,069 10,880,528
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,300 186,153 -4.76 58.01 -539,465 10,798,177
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,410 195,453 -1.22 57.75 -139,178 11,287,411
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,747 197,863 2.46
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,164 193,116 -1.11 58.29 -126,140 11,256,732
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,263 195,280 2.23
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,103 191,017 -1.60 58.29 -180,874 11,134,381
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 194,120 3.25
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -8,721 188,008 -4.43 58.29 -508,347 10,958,986
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 20,891 196,729 11.88
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,304 175,838 -0.74 58.29 -76,010 10,249,597
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 177,142 1.95
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 53.26 -532,590 9,254,071
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 19.98 199,800 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -77 173,756 -0.04 54.24 -4,177 9,425,394
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,923 173,833 -5.40 53.74 -533,292 9,342,307
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 4,491 183,756 2.51 19.98 89,730 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 5,509 179,265 3.17 16.65 91,725 2,984,762
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,037 173,756 -1.16 62.58 -127,477 10,873,824
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,963 175,793 -4.33 61.89 -492,838 10,880,005
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 62.88 -628,780 10,925,430
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-08-27 2024-08-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,580 173,756 3.32 18.41 102,728 3,198,848
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 168,176 -0.06 62.34 -6,234 10,484,092
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,900 168,276 -5.56 61.74 -611,236 10,389,529
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 61.06 -610,550 10,267,986
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 55.12 -551,150 9,269,020
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,285 178,176 4.88 16.65 137,945 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,715 169,891 1.02 8.11 13,909 1,377,816
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,291 168,176 -3.05 55.26 -292,407 9,294,247
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,709 173,467 -2.64 54.46 -256,466 9,447,533
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 49.43 -494,260 8,312,267
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.38 -453,840 7,632,500
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.16 -451,640 7,595,501
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.49 -384,890 6,472,926
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.35 -383,500 6,449,550
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,890 168,176 1.75 8.11 23,438 1,363,907
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 292 165,286 0.18 16.78 4,900 2,773,499
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,436 164,994 5.39 12.07 101,823 1,991,478
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 42.27 -422,730 6,618,176
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 3,551 166,558 2.18 8.11 28,799 1,350,785
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 6,449 163,007 4.12 12.07 77,839 1,967,494
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 41.64 -416,370 6,518,605
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 166,558 6.39 12.07 120,700 2,010,355
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,471 156,558 -4.55 39.54 -295,418 6,190,616
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 7,471 164,029 4.77 8.11 60,590 1,330,275
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,529 156,558 -1.59 39.56 -100,045 6,193,278
2024-02-28 2024-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 159,087 -5.91 39.95 -399,460 6,354,889
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,160 169,087 -1.26 36.10 -77,976 6,104,041
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,264 171,247 2.55
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,097 166,983 -1.82 36.10 -111,802 6,028,086
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 170,080 3.73
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,832 163,968 -2.28 35.91 -137,607 5,888,091
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8,479 167,800 5.32
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,208 159,321 -0.75 35.91 -43,379 5,721,217
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 160,529 2.15
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,901 157,143 -1.81 35.49 -102,956 5,577,005
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 160,044 5.35
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 40.39 -403,940 6,136,293
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -643 151,911 -0.42 40.46 -26,019 6,147,079
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,357 152,554 -5.78 39.58 -370,303 6,037,325
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,467 161,911 0.91 12.07 17,707 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,533 160,444 5.62 13.81 117,841 2,215,732
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.79 -397,880 6,044,235
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 13.81 138,100 2,235,991
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,708 151,911 -1.11 39.08 -66,747 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,708 153,619 1.12 16.78 28,660 2,577,727
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,292 151,911 -5.18 39.08 -324,043 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,292 160,203 5.46 13.81 114,513 2,212,403
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.52 -365,200 5,547,790
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.10 -390,980 5,939,416
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,075 151,911 -5.05 42.41 -342,437 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,075 159,986 5.32 19.98 161,338 3,196,520
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,925 151,911 -1.25 42.41 -81,633 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,925 153,836 1.27 18.41 35,439 2,832,121
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,825 151,911 1.89 8.11 22,911 1,231,998
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,175 149,086 5.06 13.81 99,087 2,058,878
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 40.43 -404,300 5,737,462
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 141,911 -2.06 49.55 -147,854 7,031,548
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 2,984 144,895 2.10 18.41 54,935 2,667,517
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 138,927 -2.10 49.55 -147,854 6,883,694
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,016 141,911 -4.71 49.55 -347,629 7,031,406
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -2,878 148,927 -1.90 49.26 -141,770 7,336,144
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 151,805 4.20
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 145,693 -0.80 49.20 -57,564 7,168,096
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 146,863 2.36
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 143,477 -6.52 48.39 -483,940 6,943,426
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 153,477 -1.74 48.92 -133,307 7,508,095
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 156,202 5.31
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,951 148,319 -1.95 48.92 -144,363 7,255,765
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 151,270 5.68
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,122 143,137 -0.78 50.93 -57,139 7,289,395
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,878 144,259 -5.80 50.40 -447,451 7,270,654
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,065 153,137 -3.20 58.66 -297,133 8,983,629
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,935 158,202 -3.03 58.67 -289,541 9,281,870
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3,115 163,137 -1.87 54.14 -168,643 8,832,074
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 166,252 0.00 54.61 -437 9,079,022
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,877 166,260 -3.97 54.12 -372,183 8,997,991
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 24,448 24,448
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 74,777 74,777
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -3,386 10,158 -25.00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 173,137 -0.67 34.43 -40,283 5,961,107
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 174,307 1.98
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 0 -100.00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,921 -1.15 33.64 -67,112 5,749,782
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 172,916 3.45
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 7,883 -50.00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 167,145 -1.60 34.20 -93,195 5,716,359
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,870 4.87
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,133 16,266 -33.33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,992 161,987 -1.81 34.94 -104,540 5,659,826
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 164,979 5.19
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -8,050 0 -100.00
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,050 156,846 5.41 13.10 105,455 2,054,683
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -29,450 8,050 -78.53
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -29,450 148,796 -16.52 39.93 -1,175,968 5,941,573
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 29,450 178,246 19.79 13.10 385,795 2,335,023
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -14,685 0 -100.00
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 14,685 148,796 10.95 6.55 96,187 974,614
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -40,315 14,685 -73.30
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -40,315 134,111 -23.11 45.70 -1,842,315 6,128,604
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 40,315 174,426 30.06 6.55 264,063 1,142,490
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -11,311 0 -100.00
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,311 134,111 9.21 11.29 127,701 1,514,113
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -28,689 11,311 -71.72
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18,994 122,800 -13.40 42.79 -812,829 5,255,103
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,695 141,794 -6.40 42.10 -408,208 5,970,236
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28,689 151,489 23.36 11.29 323,899 1,710,311
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,530 122,800 -5.05 46.26 -302,061 5,680,409
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,794 129,330 -8.36 45.56 -537,303 5,891,926
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 0 -100.00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,364 141,124 -3.00 48.69 -212,483 6,871,328
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 145,488 6.44
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 13,544 13,544
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 23,311 23,311
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 5,771 -50.00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,272 136,685 -1.64 49.84 -113,236 6,812,380
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 138,957 4.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 15,766 -33.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 133,186 -2.00 49.84 -135,814 6,637,990
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 135,911 6.16
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,134 24,399 -25.00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,906 128,028 -2.22 50.60 -147,044 6,478,217
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,134 130,934 6.62
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 122,800 -0.49 43.25 -25,951 5,311,346
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,400 123,400 -8.46 42.54 -484,967 5,249,559
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,889 134,800 -5.53 39.04 -307,955 5,262,053
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,111 142,689 -2.80 38.24 -157,221 5,456,998
2020-10-20 2020-10-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 146,800 -7.56 30.43 -365,148 4,466,977
2020-09-21 2020-09-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 158,800 -7.03 26.91 -322,884 4,272,832
2020-08-20 2020-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 170,800 -6.56 28.30 -339,564 4,833,128
2020-07-20 2020-07-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 182,800 -6.16 29.01 -348,072 5,302,297
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -18,613 0 -100.00
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 18,613 194,800 10.56 7.14 132,897 1,390,872
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -21,387 18,613 -53.47
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21,387 176,187 -10.82 23.80 -509,075 4,193,779
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21,387 197,574 12.14 7.14 152,703 1,410,678
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 8,803 -50.00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,044 176,187 -1.70 21.83 -66,451 3,846,162
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 179,231 5.17
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,772 11,542 -33.34
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,428 -1.16 21.10 -42,094 3,596,031
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,772 172,423 3.46
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 23,649 -25.00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 166,651 -1.61 20.00 -54,500 3,333,020
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,376 4.88
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 32,533 32,533
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 69,174 69,174
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 0 -100.00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,289 161,493 -2.59 19.21 -82,392 3,102,281
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 165,782 7.49
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)